John Glod
- Genetics top 0.5%
- Glioma Diagnosis and Treatment 14
- Mesenchymal stem cell research 11
- Oncology top 2%
- CAR-T cell therapy research 8
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism 14
- Immunology top 10%
- Molecular Biology top 5%
-
- Neuroblastoma Research and Treatments 16
-
- Sarcoma Diagnosis and Treatment 15
-
- Thyroid Cancer Diagnosis and Treatment 11
-
- Neuroendocrine Tumor Research Advances 8
- Co-authors
- Debabrata BanerjeePravin J. MishraPrasun MishraDaniel MedinaJill P. MesirovGabriela AlexeRita HumeniukHui Gao
- Cited by
- GeneticsOncologyCancer Research
- Journals
- Journal of Clinical Oncology (16 papers)Neuro-Oncology (6 papers)Cancer Research (4 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
John Glod
84 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Genetics 1.1k
- Oncology 1.3k
- Cancer Research 701
- Immunology 418
- Molecular Biology 1.4k
Countries citing papers authored by John Glod
This map shows the geographic impact of John Glod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Glod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Glod more than expected).
Fields of papers citing papers by John Glod
This network shows the impact of papers produced by John Glod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Glod. The network helps show where John Glod may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John Glod, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 31 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 6 | |
| 6 | 2022 | 10 | |
| 7 | 2021 | 104 | |
| 8 | 2020 | 21 | |
| 9 | 2019 | 58 | |
| 10 | 2018 | 14 | |
| 11 | 2017 | 20 | |
| 12 | 2016 | 2 | |
| 13 | 2012 | 73 | |
| 14 | 2012 | 112 | |
| 15 | 2011 | 6 | |
| 16 | 2011 | 142 | |
| 17 | Carcinoma-Associated Fibroblast–Like Differentiation of Human Mesenchymal Stem Cellsbreakdown → | 2008 | 733 |
| 18 | 2007 | 2 | |
| 19 | 2006 | 13 | |
| 20 | 2003 | 71 |
About John Glod
John Glod is a scholar working on Genetics, Neurology, Cancer Research, Oncology and Endocrinology, Diabetes and Metabolism, having authored 86 papers that have together received 3.3k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (16 papers), Sarcoma Diagnosis and Treatment (15 papers), Glioma Diagnosis and Treatment (14 papers), Cancer, Hypoxia, and Metabolism (14 papers), Mesenchymal stem cell research (11 papers), Thyroid Cancer Diagnosis and Treatment (11 papers), Neuroendocrine Tumor Research Advances (8 papers) and CAR-T cell therapy research (8 papers). The work is most often cited by research in Genetics (1.1k citations), Oncology (1.3k citations), Cancer Research (701 citations), Immunology (418 citations) and Molecular Biology (1.4k citations). John Glod has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Debabrata Banerjee, Pravin J. Mishra, Prasun Mishra, Daniel Medina, Jill P. Mesirov, Gabriela Alexe, Rita Humeniuk, Hui Gao, Sonia C. Picinich and Kevin Anton. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, Cancer Research, The Journal of Clinical Endocrinology & Metabolism and Experimental Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.